{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:32:07Z","timestamp":1788517927214,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai science and technology innovation action pln","award":["No. 21140902700"],"award-info":[{"award-number":["No. 21140902700"]}]},{"name":"Shanghai science and technology innovation action pln","award":["No. 21140902700"],"award-info":[{"award-number":["No. 21140902700"]}]},{"name":"Shanghai science and technology innovation action pln","award":["No. 21140902700"],"award-info":[{"award-number":["No. 21140902700"]}]},{"name":"Shanghai science and technology innovation action pln","award":["No. 21140902700"],"award-info":[{"award-number":["No. 21140902700"]}]},{"name":"Shanghai science and technology innovation action pln","award":["No. 21140902700"],"award-info":[{"award-number":["No. 21140902700"]}]},{"name":"Shanghai science and technology innovation action pln","award":["No. 21140902700"],"award-info":[{"award-number":["No. 21140902700"]}]},{"name":"Major medical and health projects of Xiamen","award":["No. 3502Z20204008"],"award-info":[{"award-number":["No. 3502Z20204008"]}]},{"name":"Major medical and health projects of Xiamen","award":["No. 3502Z20204008"],"award-info":[{"award-number":["No. 3502Z20204008"]}]},{"name":"Major medical and health projects of Xiamen","award":["No. 3502Z20204008"],"award-info":[{"award-number":["No. 3502Z20204008"]}]},{"name":"Major medical and health projects of Xiamen","award":["No. 3502Z20204008"],"award-info":[{"award-number":["No. 3502Z20204008"]}]},{"name":"Major medical and health projects of Xiamen","award":["No. 3502Z20204008"],"award-info":[{"award-number":["No. 3502Z20204008"]}]},{"name":"Major medical and health projects of Xiamen","award":["No. 3502Z20204008"],"award-info":[{"award-number":["No. 3502Z20204008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pulmonary cryptococcosis (PC) is a fungal infection that can have a variable prognosis depending on several factors. The objective of this study was to analyse the characteristics of pulmonary lesions and identify prognostic factors in patients with PC who were human immunodeficiency virus (HIV) -negative and underwent antifungal treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study enrolled patients diagnosed with PC who were negative for HIV. Symptoms, CT characteristics of pulmonary lesions, serum cryptococcal capsular antigen (CrAg) titre, underlying diseases, and duration of antifungal treatment were evaluated over a 2-year follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 63 patients (40 men and 23 women) with a mean age of 50.4\u00a0years were included. Half of the patients (50.8%) were asymptomatic, and the most common symptoms were cough (44.4%), expectoration (27.0%), and fever (17.5%). Pulmonary lesions were mainly present in the peripheral and lower lobes of the lung, with 35 cases classified as nodular-type lesions and 28 cases classified as mass-type lesions. At the first, third, sixth, 12th, and 24th-month follow-ups, the median proportion of residual pulmonary lesions were 59.6%, 29.9%, 12.2%, 9.6%, and 0.0%, respectively. During antifungal treatment, the lesions of 33 patients achieved complete response, while the remaining 30 patients did not. Compared with the non-CR group, the CR group had a lower baseline serum CrAg titre (median, 1:20 vs 1:80, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), smaller pulmonary lesion size (median area, 1.6\u00a0cm<jats:sup>2<\/jats:sup> vs 6.3\u00a0cm<jats:sup>2<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), lower Hounsfield-units (HU) radiodensity (median, \u2212\u00a060.0 HU vs \u2212\u00a028.5 HU, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), more nodular-type lesions (72.7% vs 36.7%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), and fewer air-bronchogram signs (18.2% vs 43.3%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Multivariate logistic regression analysis showed that a larger lesion size on chest CT scans was associated with a lower likelihood of achieving complete response [OR: 0.89; 95% CI (0.81\u20130.97); <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PC was more commonly observed in HIV-negative men, and chest CT scans mostly revealed nodular-type lesions. After antifungal treatment, patients with smaller lesions had a better prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08131-0","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T09:03:29Z","timestamp":1678784609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lesion size as a prognostic factor in the antifungal treatment of pulmonary cryptococcosis: a retrospective study with chest CT pictorial review of 2-year follow up"],"prefix":"10.1186","volume":"23","author":[{"given":"Yu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongni","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"issue":"11","key":"8131_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","volume":"378","author":"SF Molloy","year":"2018","unstructured":"Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, et al. Antifungal combinations for treatment of Cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004\u201317.","journal-title":"N Engl J Med"},{"issue":"1","key":"8131_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0039-3400280","volume":"41","author":"S Zavala","year":"2020","unstructured":"Zavala S, Baddley JW. Cryptococcosis. Semin Respir Crit Care Med. 2020;41(1):69\u201379.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"8131_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1055\/s-0035-1562895","volume":"36","author":"CC Chang","year":"2015","unstructured":"Chang CC, Sorrell TC, Chen SC. Pulmonary Cryptococcosis. Semin Respir Crit Care Med. 2015;36(5):681\u201391.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"8131_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/mmy\/myy086","volume":"57","author":"F Setianingrum","year":"2019","unstructured":"Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133\u201350.","journal-title":"Med Mycol"},{"issue":"165","key":"8131_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165): 165rv113.","journal-title":"Sci Transl Med."},{"issue":"1","key":"8131_CR6","first-page":"14","volume":"44","author":"LA Chen","year":"2021","unstructured":"Chen LA, She DY, Liang ZX, Liang LL, Chen RC, Ye F, Li YP, Zhou Y, Chen XH, Fang SF, et al. A prospective multi-center clinical investigation of HIV-negative pulmonary cryptococcosis in China. Zhonghua Jie He He Hu Xi Za Zhi. 2021;44(1):14\u201327.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"8131_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mib.2017.10.012","volume":"40","author":"ER Ballou","year":"2017","unstructured":"Ballou ER, Johnston SA. The cause and effect of Cryptococcus interactions with the host. Curr Opin Microbiol. 2017;40:88\u201394.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"8131_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179\u2013206.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"8131_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/myc.12966","volume":"62","author":"X Hou","year":"2019","unstructured":"Hou X, Kou L, Han X, Zhu R, Song L, Liu T. Pulmonary cryptococcosis characteristics in immunocompetent patients: a 20-year clinical retrospective analysis in China. Mycoses. 2019;62(10):937\u201344.","journal-title":"Mycoses"},{"key":"8131_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/703407","volume":"2015","author":"H Yamakawa","year":"2015","unstructured":"Yamakawa H, Yoshida M, Yabe M, Baba E, Okuda K, Fujimoto S, Katagi H, Ishikawa T, Takagi M, Kuwano K. Correlation between clinical characteristics and chest computed tomography findings of pulmonary cryptococcosis. Pulm Med. 2015;2015: 703407.","journal-title":"Pulm Med"},{"issue":"6","key":"8131_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00408-013-9506-0","volume":"191","author":"MD Guimar\u00e3es","year":"2013","unstructured":"Guimar\u00e3es MD, Marchiori E, Meirelles GS, Hochhegger B, Santana PR, Gross JL, Bitencourt AG, Boonsirikamchai P, Godoy MC. Fungal infection mimicking pulmonary malignancy: clinical and radiological characteristics. Lung. 2013;191(6):655\u201362.","journal-title":"Lung"},{"issue":"1","key":"8131_CR12","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.1038\/s41598-020-66094-7","volume":"10","author":"J Qu","year":"2020","unstructured":"Qu J, Zhang X, Lu Y, Liu X, Lv X. Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in Western China. Sci Rep. 2020;10(1):9387.","journal-title":"Sci Rep"},{"issue":"4","key":"8131_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3314\/mmj.20.001","volume":"61","author":"K Izumikawa","year":"2020","unstructured":"Izumikawa K, Kakeya H, Sakai F, Shibuya K, Sugita T, Takazono T, Takata T, Tashiro M, Teruya K, Nakamura S, et al. Executive summary of JSMM clinical practice guidelines for diagnosis and treatment of cryptococcosis 2019. Med Mycol J. 2020;61(4):61\u201389.","journal-title":"Med Mycol J"},{"issue":"Suppl 7","key":"8131_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/imj.15590","volume":"51","author":"CC Chang","year":"2021","unstructured":"Chang CC, Hall V, Cooper C, Grigoriadis G, Beardsley J, Sorrell TC, Heath CH. Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology\/oncology setting, 2021. Intern Med J. 2021;51(Suppl 7):118\u201342.","journal-title":"Intern Med J"},{"issue":"9","key":"8131_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13543","volume":"33","author":"JW Baddley","year":"2019","unstructured":"Baddley JW, Forrest GN. Cryptococcosis in solid organ transplantation-guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9): e13543.","journal-title":"Clin Transplant"},{"issue":"6","key":"8131_CR16","first-page":"438","volume":"19","author":"T Suwatanapongched","year":"2013","unstructured":"Suwatanapongched T, Sangsatra W, Boonsarngsuk V, Watcharananan SP, Incharoen P. Clinical and radiologic manifestations of pulmonary cryptococcosis in immunocompetent patients and their outcomes after treatment. Diagn Interv Radiol. 2013;19(6):438\u201346.","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"8131_CR17","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1038\/s41598-022-09794-6","volume":"12","author":"DX Wang","year":"2022","unstructured":"Wang DX, Zhang Q, Wen QT, Ding GX, Wang YG, Du FX, Zhang TY, Zheng XY, Cong HY, Du YL, et al. Comparison of CT findings and histopathological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients. Sci Rep. 2022;12(1):5712.","journal-title":"Sci Rep"},{"issue":"2","key":"8131_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1378\/chest.129.2.333","volume":"129","author":"WC Chang","year":"2006","unstructured":"Chang WC, Tzao C, Hsu HH, Lee SC, Huang KL, Tung HJ, Chen CY. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest. 2006;129(2):333\u201340.","journal-title":"Chest"},{"issue":"12","key":"8131_CR19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8131_CR20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8131_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.21037\/apm-21-127","volume":"10","author":"KB Cheng","year":"2021","unstructured":"Cheng KB, Wu ZH, Liang S, Li HP, Xu JF. Associations of serum cryptococcal antigen with different of clinical characteristics: a comprehensive analysis of 378 pulmonary cryptococcosis patients. Ann Palliat Med. 2021;10(1):681\u201393.","journal-title":"Ann Palliat Med"},{"issue":"6","key":"8131_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1128\/jcm.33.6.1588-1591.1995","volume":"33","author":"YS Liaw","year":"1995","unstructured":"Liaw YS, Yang PC, Yu CJ, Chang DB, Wang HJ, Lee LN, Kuo SH, Luh KT. Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis. J Clin Microbiol. 1995;33(6):1588\u201391.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"8131_CR23","doi-asserted-by":"publisher","first-page":"ofw167","DOI":"10.1093\/ofid\/ofw167","volume":"3","author":"JF Fisher","year":"2016","unstructured":"Fisher JF, Valencia-Rey PA, Davis WB. Pulmonary cryptococcosis in the immunocompetent patient-many questions, some answers. Open Forum Infect Dis. 2016;3(3):ofw167.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"8131_CR24","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1128\/JCM.00920-17","volume":"55","author":"MP Cheng","year":"2017","unstructured":"Cheng MP, Nguyen TT, Parkes LO, Dufresne PJ, Sheppard DC. Cross-reacting Ustilago maydis causing false-positive cryptococcal antigen test results. J Clin Microbiol. 2017;55(10):3135\u20137.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08131-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T09:03:53Z","timestamp":1678784633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08131-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8131"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08131-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the Zhongshan Hospital, Fudan University (No.B2022-288R). The need for written informed consent was waived by the Medical Ethics Committee of the Zhongshan Hospital, Fudan University owing to retrospective nature of the study. Patient care was conducted in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}